Northwest Biotherapeutics (NWBO) Net Margin Growth (3y) (2013 - 2026)
Northwest Biotherapeutics (NWBO) Net Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | - |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,023.69 Bn | 1,023.69 Bn | - | - |
| 4 | BeOne Medicines | 468.59 Bn | 463.80 Bn | 1.35 Bn | 9,283.00 |
| 5 | Vertex Pharmaceuticals | 123.01 Bn | 115.76 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 70.29 Bn | 61.53 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 63.33 Bn | 63.33 Bn | - | - |
| 8 | Argenx Se | 55.70 Bn | 50.52 Bn | 1.41 Bn | 6,537.00 |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | 7,218.00 |
| 10 | Northwest Biotherapeutics | 275.76 Mn | 273.98 Mn | - | 56,708.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,708.00 |
| Dec 31, 2025 | 492,619.00 |
| Sep 30, 2025 | 235,657.00 |
| Jun 30, 2025 | -594,671.00 |
| Mar 31, 2025 | -170,175.00 |
| Sep 30, 2024 | -672,387.00 |
| Jun 30, 2024 | -465,029.00 |
| Mar 31, 2024 | -492,278.00 |
| Dec 31, 2023 | 5.25 Mn |
| Sep 30, 2023 | 8.39 Mn |
| Jun 30, 2023 | 289.52 Mn |
| Mar 31, 2023 | -171,604.00 |
| Dec 31, 2022 | -542,643.00 |
| Sep 30, 2022 | -1.49 Mn |
| Jun 30, 2022 | -625,740.00 |
| Mar 31, 2022 | 265,171.00 |
| Sep 30, 2021 | -59,497.00 |
| Jun 30, 2021 | 994,930.00 |
| Mar 31, 2021 | 2.22 Mn |
| Dec 31, 2020 | 3.26 Mn |